"FDA approved" may be the most misused phrase in health and wellness. People apply it to vapes, food dyes, creatine and vitamin B12 alike, but those products sit in completely different legal categories. Some need FDA approval before they can be sold, some only need FDA permission of a different kind, and some never go through FDA review at all. Here is how it actually works.
What "FDA approved" really means
Strictly speaking, approval is something the FDA gives to drugs (and, in a similar process, to biologics and high-risk medical devices). Before a new drug can be sold, its maker files an application showing:
- that the drug is safe and effective for a specific use, and that its benefits outweigh its risks for the people who will take it;
- that the proposed label describes those benefits and risks accurately;
- that it can be manufactured with consistent identity, strength, quality and purity.
Approval is tied to that use, dose and population. Doctors may legally prescribe an approved drug "off label" for something else when they judge it medically appropriate, but the FDA has not reviewed it for that use. Generic drugs go through a shorter application that shows they match an already approved drug.
Product by product
Vitamin B12: approved or not, depending on the form
- Injectable B12 (cyanocobalamin) is an FDA-approved prescription drug for B12 deficiency, including pernicious anemia.
- Nasal B12 (Nascobal) is also an FDA-approved prescription drug.
- B12 tablets and gummies on a store shelf are dietary supplements. They are legal to sell, but they are not FDA approved.
Same vitamin, two different categories. What decides it is how the product is made, labeled and intended to be used.
Creatine and other dietary supplements: not approved
Under a 1994 law called DSHEA, the FDA does not have the authority to approve dietary supplements before they go on sale. Companies are responsible for making sure their products are safe and labeled truthfully, they must follow good manufacturing practice rules, and a brand-new dietary ingredient requires a safety notice to the FDA at least 75 days before it is sold. The FDA's role mostly begins after a product is on the market, when it can act against unsafe or mislabeled products.
That is why supplement labels that make claims about the body carry the line: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."
Creatine has one extra wrinkle. In 2020 the FDA reviewed a GRAS notice for adding creatine monohydrate to foods such as protein bars and drinks, and replied that it had "no questions." That is a meaningful review, but the FDA itself says such a letter is not an approval.
Food ingredients and GRAS
Most ingredients added to food are either approved food additives or "generally recognized as safe" (GRAS), meaning qualified experts agree they are safe for that use. For decades companies could reach that conclusion themselves without telling the FDA. In August 2026 the Department of Health and Human Services proposed making GRAS notification to the FDA mandatory. As of this writing it is a proposal, not a final rule.
Food dyes: actually approved
Color additives are the one item on our list that genuinely require FDA approval before use. Every permitted color is listed in federal regulations, and the FDA tests and certifies each batch of synthetic dyes such as Red No. 40 before it can be sold.
Approval is not permanent, though:
- In January 2025 the FDA revoked Red No. 3 for food and ingested drugs under the Delaney Clause, a law that bans any additive shown to cause cancer in animals. Food makers have until January 2027 to remove it. The FDA noted that the rat cancer finding does not appear to apply to people.
- In April 2025 the FDA announced a plan to phase out petroleum-based dyes. It has since revoked Orange B and proposed revoking Citrus Red No. 2, and its tracking page now sets the end of 2027 as the target for removing the remaining synthetic dyes.
- The FDA approved several colors from natural sources in 2025, including galdieria blue, gardenia blue and calcium phosphate.
Vapes: authorized, not approved
E-cigarettes have been regulated as tobacco products since 2016. A vape can be legally sold only if the FDA issues a "marketing granted order," meaning the agency found that allowing it on the market is "appropriate for the protection of the public health." That is a population-level judgment, not a finding that the product is safe. As of August 2026 the FDA lists 48 authorized e-cigarette products from five companies (Vuse, NJOY, Logic, JUUL and Glas). The FDA states plainly that authorization "does not mean these products are safe, nor are they 'FDA approved.'"
Two more categories people mix up
- Medical devices: a high-risk device is "approved," but most devices are "cleared," which means the FDA found them substantially equivalent to a device already on the market.
- Cosmetics: they do not need FDA approval at all, except for any color additives they contain.
Where research peptides fit
Research peptides such as BPC-157, TB-500 and MOTS-c are not FDA approved for any use in people or animals. They are sold for laboratory research, and they are a different category from supplements: the FDA treats a peptide intended for human use as an unapproved drug.
A "research use only" label does not change that if the seller's marketing points to human use. In warning letters from late 2024 through 2026, the FDA told several peptide sellers that their websites showed the products were "intended to be drugs for human use" despite those labels.
Compounding is a separate track. In 2023 the FDA placed many popular peptides on a list of substances that may pose significant safety risks for pharmacy compounding. In April 2026 the nominations for many of them were withdrawn, taking them off that list, and in July 2026 an FDA advisory committee reviewed seven and recommended six, including BPC-157 and MOTS-c, for the list pharmacies may compound from. That vote was advisory. In late October 2026, HHS said that while rulemaking continues it will not take action against 503A pharmacies that compound those six peptides for individual patients under strict sourcing and testing conditions. That is an enforcement policy, not an approval: the peptides are still not FDA-approved drugs, and products sold as research chemicals are excluded. For background, see what the July 2026 FDA vote actually means.
What "not approved" does and doesn't mean
"Not FDA approved" means the FDA has not reviewed that product for that use. It does not prove the product is unsafe or that it does not work. Plenty of safe, useful products, from multivitamins to most cosmetics, are not FDA approved because the law never asks them to be.
It does mean that nobody outside the seller has had to show the FDA evidence of safety, effectiveness, purity or dose accuracy for that product. For research compounds that gap matters, which is why we put so much weight on lot numbers and certificates of analysis.
And "approved" does not mean risk-free. It means the FDA judged that the benefits outweigh the known risks for a specific use, as described on the label. Approved drugs carry warnings, side effects get discovered after approval, and, as Red No. 3 shows, an approval can be withdrawn.
How to check a claim yourself
- Drugs: search the FDA's Drugs@FDA database for the product name.
- Vapes: check the FDA's list of authorized e-cigarette products.
- Supplements: look for the "not evaluated by the FDA" statement. If a supplement claims to be "FDA approved," treat that as a red flag.
Key references
- U.S. Food and Drug Administration. Development and approval process for drugs.
- U.S. Food and Drug Administration. Understanding unapproved use of approved drugs "off label".
- U.S. Food and Drug Administration. Questions and answers on dietary supplements.
- U.S. Food and Drug Administration. GRAS notice 931, creatine monohydrate: response letter, 2020.
- U.S. Department of Health and Human Services. Fact sheet on the proposed GRAS rule, August 2026.
- U.S. Food and Drug Administration. Color additives in foods, revocation of Red No. 3 and tracking the removal of petroleum-based food dyes.
- U.S. Food and Drug Administration. E-cigarettes authorized by the FDA.
- U.S. Food and Drug Administration. How cosmetics are not FDA approved, but are FDA regulated.
- U.S. Food and Drug Administration. Warning letter to Peak Performance Peptides, August 24, 2026.
- Baker Hostetler. HHS issues enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances, October 2026.
- U.S. Food and Drug Administration. Bulk drug substances that may present significant safety risks in compounding.
This post is educational and is not legal or medical advice.